Cellectis
Cellectis develops CAR T-cell therapies using gene editing technologies like TALEN®, creating customizable, off-the-shelf immune treatments for various cancers.
Specifications
- LocationNorth Carolina, USA
- Industry Role
- Colors
Cellectis develops CAR T-cell therapies using gene editing technologies like TALEN®, creating customizable, off-the-shelf immune treatments for various cancers.
